National Path Lab

Infectious Disease Risk

Infectious disease risk refers to the likelihood of exposure to and infection with disease-causing organisms, based on lifestyle, occupation, travel, and immune status. Some infections — particularly HIV and hepatitis B/C — can remain silent for years while causing progressive damage, making risk-based screening essential rather than optional.

Unlike many other health risks on this page, infectious disease risk is often time-sensitive: identifying and treating an infection early can prevent both personal complications and further transmission to others.

At National Path Lab (NPL), confidential testing is available for a wide range of infectious disease risks, from sexually transmitted infections to travel-related illnesses.

Tests Available at NPL

CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE PCR QUALITATIVE

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT AFTER 7 DAYS

Rs. 12000

View DetailBook Now

MALARIA ANTIGEN

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 500

View DetailBook Now

HAINS MYCOBACTERIUM TUBERCULOSIS FIRST LINE DRUG RESISTANCE PROFILE

Turn Around Time
SAMPLE DAILY BY 8:00 PM, REPORT AFTER 7-10 DAYS

Rs. 5500

View DetailBook Now

HEPATITIS B SURFACE ANTIBODY (ANTI HBS)

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 2000

View DetailBook Now

MALARIA PARASITE, SMEAR

Turn Around Time
SAMPLE DAILY BY 5:00 PM REPORT ON SAME DAY

Rs. 300

View DetailBook Now

HEPATITIS B SURFACE ANTIGEN; HBSAG QUANTITATIVE

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 1600

View DetailBook Now

MALARIA BY RT-PCR, BLOOD

Turn Around Time
SAMPLE DAILY BY 7:00 PM, REPORT AFTER 7-10 DAYS

Rs. 6000

View DetailBook Now

CULTURED AFB OTHER THAN TUBERCULOSIS (MOTT), DST FOR SLOW GROWERS

Turn Around Time
SAMPLE DAILY BY 8:00 PM, REPORT AFTER 21 DAYS

Rs. 16000

View DetailBook Now

HIV 1 & 2 ANTIBODIES, WESTERN BLOT

Turn Around Time
SAMPLE DAILY BY 7:00 PM, REPORT AFTER 7 DAYS

Rs. 6000

View DetailBook Now

DENGUE VIRUS PCR QUALITATIVE

Turn Around Time
SAMPLE DAILY BY 8:00 PM, REPORT AFTER 7-10 DAYS

Rs. 6000

View DetailBook Now

HIV I & II ANTIBODY INCLUDING P24 ANTIGEN

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 2000

View DetailBook Now

About Infectious Disease Risk

Who Is at Risk?

Infectious disease risk depends heavily on exposure circumstances:

Non-Modifiable Factors

Modifiable Factors

Occupational exposure (healthcare workers and similar roles)

Unprotected sexual contact or multiple partners

Immunocompromised status due to an underlying medical condition

Sharing needles or injection equipment

Geographic residence in or travel to areas with higher disease prevalence

Incomplete vaccination status

Lack of protective measures during travel to endemic areas

Close, prolonged contact with an infected individual without appropriate precautions

Test

Clinical Relevance

HIV Antigen/Antibody Test

The standard screening test for HIV.

Hepatitis B Panel (HBsAg, Anti-HBs, Anti-HBc)

Assesses hepatitis B infection and immunity status.

Hepatitis C Antibody (Anti-HCV)

Screens for hepatitis C exposure.

STI Panel (Chlamydia, Gonorrhea, Syphilis)

Screens for common sexually transmitted infections.

Tuberculosis Testing

Relevant for occupational or close-contact exposure.

Malaria / Dengue Testing

Relevant for travel to endemic areas with fever.

Related Packages

NPL VITAL CARE HEALTH CHECKUP PACKAGE

Test Includes
15 Tests

Rs. 6000

View DetailBook Now

BASIC STI PROFILE

Test Includes
11 Tests

Rs. 8800

View DetailBook Now

Frequently Asked Questions

Because some of the most serious infections — HIV, hepatitis B, hepatitis C — are frequently asymptomatic for years while still causing progressive damage. Risk-based screening is the only reliable way to detect them early.
Yes, NPL follows appropriate confidentiality protocols for sensitive testing. Discuss any specific privacy concerns with our team when booking.
This varies by infection — different tests have different detection windows. Your doctor can advise on the appropriate timing for your specific exposure.
Yes, generally recommended if you test positive for an STI, so they can also be tested and treated to prevent reinfection.
Yes, in most cases. Hepatitis C is curable in the majority of patients with modern treatment, HIV is a manageable chronic condition with modern antiretroviral therapy, and most STIs are treatable — early diagnosis is what makes effective treatment possible.